Page last updated: 2024-08-22

cladribine and Virus Diseases

cladribine has been researched along with Virus Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Araujo, C; Artifoni, M; Cohen-Aubart, F; de Menthon, M; Donadieu, J; Dromer, C; Fontenoy, AM; Genereau, T; Guillevin, L; Hamidou, M; Haroche, J; Hermine, O; Jullien, D; Kahn, JE; Lorillon, G; Maillard, H; Néel, A; Tazi, A; Tessoulin, B	1

Reviews

1 review(s) available for cladribine and Virus Diseases

Article	Year
Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review. British journal of haematology, 2020, Volume: 189, Issue:5 Topics: Adult; Age of Onset; Aged, 80 and over; Antimetabolites; Cladribine; Dose-Response Relationship, Drug; Female; France; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Neutropenia; Proportional Hazards Models; Remission Induction; Retrospective Studies; Sepsis; Virus Diseases	2020

Article

Year

Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review.

British journal of haematology, 2020, Volume: 189, Issue:5

Topics: Adult; Age of Onset; Aged, 80 and over; Antimetabolites; Cladribine; Dose-Response Relationship, Drug; Female; France; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Neutropenia; Proportional Hazards Models; Remission Induction; Retrospective Studies; Sepsis; Virus Diseases

2020